RBC Capital " We Except More Money Flow Coming into VRTX.. read link. 4/19
Vertex’s post-test surge holds up as investors clamor to company
April 19, 2013, 10:45 AM
By Russ Brit
Michael Yee, analyst for RBC Capital , We believe the stock has been under-owned relative to other mid-to-large cap biotechs and with this clinical de-risking event, we expect more money flow to come in to further support our bullish thesis,” Yee said in his note.